ENDRA Life Sciences (NDRA) Interest Coverage Ratio Growth (5y) (2021 - 2026)
ENDRA Life Sciences (NDRA) Interest Coverage Ratio Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.86% |
| Sep 30, 2025 | -13.55% |
| Jun 30, 2025 | 20.46% |
| Mar 31, 2025 | 41.32% |
| Sep 30, 2024 | 25.05% |
| Jun 30, 2024 | 31.79% |
| Mar 31, 2024 | 27.50% |
| Dec 31, 2023 | 8.29% |
| Sep 30, 2023 | 41.31% |
| Jun 30, 2023 | 23.72% |
| Mar 31, 2023 | 21.58% |
| Dec 31, 2022 | -15.28% |
| Sep 30, 2022 | -7.97% |
| Jun 30, 2022 | -44.29% |
| Mar 31, 2022 | -88.57% |
| Dec 31, 2021 | -214.93% |
| Sep 30, 2021 | -59.39% |
| Jun 30, 2021 | -53.87% |
| Mar 31, 2021 | 58.23% |